Search - tctmd.com

Displaying 1 - 20 of 120

Sort: Relevancy | Date

Presentation TCT 2025

Regulatory Approvals for Therapies for Patients with “Not Suitable for Conventional Therapy?"

Presenter: Jeffrey Popma

October 28, 2025

Presentation TCT 2025

TCT 732: Peri-device Leak and Clinical Outcomes After LAAC Using a Fluoropolymer Coated Device in Patients with Paroxysmal vs. Persistent Atrial Fibrillation: HEAL-LAA Post Approval Study Sub-analysis

Presenter: Thomas E. Waggoner

October 28, 2025

Presentation TCT 2025

Moving to Randomized SCAI A Shock CAD Phenotype Approval Studies: Barriers & Solutions

Presenter: Mitchell W. Krucoff

October 28, 2025

Presentation TCT 2025

Electrosurgical Tools in Structural Heart Interventions: How to Drive Best Practices, Device Development, and Regulatory Approval

Presenter: Adam B. Greenbaum

October 28, 2025

Presentation TCT 2025

Pragmatic, Adapted, and Augmented Trials: Ready for Regulatory Approval

Presenter: Sreekanth Vemulapalli

October 27, 2025

Presentation TCT 2025

TCT 704: Outcomes After LAAC Using a Fluoropolymer Coated Device in Patients of Historically Underrepresented Racial and Ethnic Groups: A Sub-analysis of the HEAL-LAA Post Approval Study

Presenter: Seun Alli

October 27, 2025

Presentation TCT 2025

Comparative Outcomes of ICE vs. TEE Guided LACC with Amulet Device: Insights from EMERGE LAA Post-Approval Study

Presenter: Mohamad A. Alkhouli

October 26, 2025

Presentation TCT 2025

TCT 178: Use of the AGENT Paclitaxel-Coated Balloon in the United States Shortly After FDA Approval: Early Results from the AGENT Post-Approval Study

Presenter: Christina Lalani

October 26, 2025

Presentation NY Valves 2025

Outcomes of TEE vs. ICE-guided Left Atrial Appendage Closure Using a Fluoropolymer Coated Device: A Sub-analysis of the HEAL-LAA Post Approval Study

Presenter: Seun Alli

June 26, 2025

Presentation NY Valves 2025

Outcomes in Patients Discharged on OAC vs. DAPT After Left Atrial Appendage Occlusion Using a Fluoropolymer Coated Device: A Sub-analysis of the HEAL-LAA Post Approval Study

Presenter: Seun Alli

June 25, 2025

Presentation NY Valves 2025

Outcomes of Same-day vs. Delayed Discharge After LAAC Using a Fluoropolymer Coated Device: HEAL-LAA Post Approval Study Sub-analysis

Presenter: Jeremiah P. Depta

June 25, 2025

Presentation Controversies and Advances 2025

FDA Approval for TTVI

Presenter: David J. Cohen

January 30, 2025

Presentation TCT 2024

TCT 920: Early US Commercial Experience With an Intra-Annular, Self-Expandable Valve in High-Risk Patients: 30-Day Results From the Navitor™ Post-Approval Study

Presenter: Santiago Garcia

October 30, 2024

Presentation TCT 2024

Left Atrial Appendage Closure with a Novel Fluoropolymer-Coated Device: The HEAL-LAA Post-Approval Clinical Study

Presenter: Seun Alli

October 30, 2024

Presentation TCT 2024

One-Year Real-World Outcomes with the Amulet LAAO: The EMERGE LAA Post-Approval Study

Presenter: Atman Shah

October 30, 2024

Presentation TCT 2024

How to Interpret Patient Reported Outcomes (PROs): Lessons from the Regulatory Approval Trials in TTVI

Presenter: Suzanne Arnold

October 30, 2024

Presentation TCT 2024

What’s Next - Going into 2025

Presenter: Vijay Iyer

October 28, 2024

Presentation TCT 2024

Building Real-world Clinical Evidence: Global Paradise System (GPS) Registry

Presenter: Naomi Fisher

October 28, 2024

Presentation TCT 2024

Getting Started: Establishing a Patient Care Pathway

Presenter: Matheen Khuddus

October 28, 2024

Presentation TCT 2024

Science of Ultrasound RDN

Presenter: Michael Joner

October 28, 2024

Advertisement

Regulatory Approvals for Therapies for Patients with “Not Suitable for Conventional Therapy?"

TCT 732: Peri-device Leak and Clinical Outcomes After LAAC Using a Fluoropolymer Coated Device in Patients with Paroxysmal vs. Persistent Atrial Fibrillation: HEAL-LAA Post Approval Study Sub-analysis

Moving to Randomized SCAI A Shock CAD Phenotype Approval Studies: Barriers & Solutions

Electrosurgical Tools in Structural Heart Interventions: How to Drive Best Practices, Device Development, and Regulatory Approval

Pragmatic, Adapted, and Augmented Trials: Ready for Regulatory Approval

TCT 704: Outcomes After LAAC Using a Fluoropolymer Coated Device in Patients of Historically Underrepresented Racial and Ethnic Groups: A Sub-analysis of the HEAL-LAA Post Approval Study

Comparative Outcomes of ICE vs. TEE Guided LACC with Amulet Device: Insights from EMERGE LAA Post-Approval Study

TCT 178: Use of the AGENT Paclitaxel-Coated Balloon in the United States Shortly After FDA Approval: Early Results from the AGENT Post-Approval Study

Outcomes of TEE vs. ICE-guided Left Atrial Appendage Closure Using a Fluoropolymer Coated Device: A Sub-analysis of the HEAL-LAA Post Approval Study

Outcomes in Patients Discharged on OAC vs. DAPT After Left Atrial Appendage Occlusion Using a Fluoropolymer Coated Device: A Sub-analysis of the HEAL-LAA Post Approval Study

Outcomes of Same-day vs. Delayed Discharge After LAAC Using a Fluoropolymer Coated Device: HEAL-LAA Post Approval Study Sub-analysis

FDA Approval for TTVI

TCT 920: Early US Commercial Experience With an Intra-Annular, Self-Expandable Valve in High-Risk Patients: 30-Day Results From the Navitor™ Post-Approval Study

Left Atrial Appendage Closure with a Novel Fluoropolymer-Coated Device: The HEAL-LAA Post-Approval Clinical Study

One-Year Real-World Outcomes with the Amulet LAAO: The EMERGE LAA Post-Approval Study

How to Interpret Patient Reported Outcomes (PROs): Lessons from the Regulatory Approval Trials in TTVI

What’s Next - Going into 2025

Building Real-world Clinical Evidence: Global Paradise System (GPS) Registry

Getting Started: Establishing a Patient Care Pathway

Science of Ultrasound RDN

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content